Overexpression of PGC‑1α enhances cell proliferation and tumorigenesis of HEK293 cells through the upregulation of Sp1 and Acyl-CoA binding protein

Shin,Sung-Won; Yun,Seong-Hoon; Park,Eun-Seon; Jeong,Jin-Sook; Kwak,Jong-Young; Park,Joo-In

doi:10.3892/ijo.2015.2834

Overexpression of PGC‑1α enhances cell proliferation and tumorigenesis of HEK293 cells through the upregulation of Sp1 and Acyl-CoA binding protein

Authors:
- Sung-Won Shin
- Seong-Hoon Yun
- Eun-Seon Park
- Jin-Sook Jeong
- Jong-Young Kwak
- Joo-In Park
View Affiliations

Affiliations: Department of Biochemistry, Dong-A University College of Medicine, Busan, Republic of Korea, Department of Pathology, Dong-A University College of Medicine, Busan, Republic of Korea
Published online on: January 12, 2015 https://doi.org/10.3892/ijo.2015.2834
Pages: 1328-1342

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Peroxisome proliferator-activated receptor γ coactivator-1α (PGC‑1α), a coactivator interacting with multiple transcription factors, regulates several metabolic processes. Although recent studies have focused on the role of PGC‑1α in cancer, the underlying molecular mechanism has not been clarified. Therefore, we evaluated the role of PGC‑1α in cell proliferation and tumorigenesis using human embryonic kidney (HEK)293 cells and colorectal cancer cells. We established stable HEK293 cell lines expressing PGC‑1α and examined cell proliferation, anchorage-independent growth, and oncogenic potential compared to parental HEK293 cells. To identify the molecular PGC‑1α targets for increased cell proliferation and tumorigenesis, the GeneFishing™ DEG (differentially expressed genes) screening system was used. Western blot analysis and immunofluorescence staining were performed for a regulated gene product to confirm the results. Forced expression of PGC‑1α in HEK293 cells promoted cell proliferation and anchorage-independent growth in soft agar. In addition, HEK293 cells that highly expressed PGC‑1α showed enhanced tumor formation when subcutaneously injected into the bilateral flanks of immunodeficient mice. The results of the GeneFishing DEG screening system identified one upregulated gene (Acyl-CoA binding protein; ACBP). Real-time RT-PCR, western blot analysis, and immunofluorescence staining showed that ACBP was markedly increased in HEK293 cells stably overexpressing PGC‑1α (PGC‑1α-HEK293 cells) compared to those expressing an empty vector. In PGC‑1α, ACBP, and specificity protein 1 (Sp1) siRNA knockdown experiments in PGC‑1α-HEK293 and SNU-C4 cells, we also observed inhibition of cell proliferation, reduced expression of antioxidant enzymes, and increased H2O2-induced reactive oxygen species production and apoptosis. These findings suggest that PGC‑1α may promote cell proliferation and tumorigenesis through upregulation of ACBP. We provide evidence that increased Sp1 expression might contribute to enhanced ACBP expression by PGC‑1α. The current results also suggest that PGC‑1α, whose expression is related to enhanced cell proliferation and tumorigenesis, may be a good candidate molecular target for cancer therapy.

View Figures

View References

1	Puigserver P, Wu ZD, Park CW, Graves R, Wright M and Spiegelman BM: A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell. 92:829–839. 1998. View Article : Google Scholar : PubMed/NCBI
2	Finck BN and Kelly DP: PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest. 116:615–622. 2006. View Article : Google Scholar : PubMed/NCBI
3	Handschin C and Spiegelman BM: Peroxisome proliferator-activated receptor γ coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev. 27:728–735. 2006. View Article : Google Scholar : PubMed/NCBI
4	Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC and Spiegelman BM: Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell. 98:115–124. 1999. View Article : Google Scholar : PubMed/NCBI
5	Vega RB, Huss JM and Kelly DP: The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor α in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol. 20:1868–1876. 2000. View Article : Google Scholar : PubMed/NCBI
6	Wang YX, Lee CH, Tiep S, Yu RT, Ham J, Kang H and Evans RM: Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity. Cell. 113:159–170. 2003. View Article : Google Scholar : PubMed/NCBI
7	Herzig S, Long F, Jhala US, Hedrick S, Quinn R, Bauer A, Rudolph D, Schutz G, Yoon C, Puigserver P, Spiegelman B and Montminy M: CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature. 413:179–183. 2001. View Article : Google Scholar : PubMed/NCBI
8	Yoon JC, Puigserver P, Chen GX, Donovan J, Wu ZD, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK, Newgard CB and Spiegelman BM: Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature. 413:131–138. 2001. View Article : Google Scholar : PubMed/NCBI
9	Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN, Lowell BB, Bassel-Duby R and Spiegelman BM: Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres. Nature. 418:797–801. 2002. View Article : Google Scholar : PubMed/NCBI
10	St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jäger S, Handschin C, Zheng K, Lin J, Yang W, Simon DK, Bachoo R and Spiegelman BM: Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell. 127:397–408. 2006. View Article : Google Scholar : PubMed/NCBI
11	Liu C, Li S, Liu T, Borjigin J and Lin JD: Transcriptional coactivator PGC-1α integrates the mammalian clock and energy metabolism. Nature. 447:477–481. 2007. View Article : Google Scholar : PubMed/NCBI
12	Knutti D, Kaul A and Kralli A: A tissue-specific coactivator of steroid receptors, identified in a functional genetic screen. Mol Cell Biol. 20:2411–2422. 2000. View Article : Google Scholar : PubMed/NCBI
13	Tcherepanova I, Puigserver P, Norris JD, Spiegelman BM and McDonnell DP: Modulation of estrogen receptor-α transcriptional activity by the coactivator PGC-1. J Biol Chem. 275:16302–16308. 2000. View Article : Google Scholar : PubMed/NCBI
14	Delerive P, Wu YF, Burris TP, Chin WW and Suen CS: PGC-1 functions as a transcriptional coactivator for the retinoid X receptors. J Biol Chem. 277:3913–3917. 2002. View Article : Google Scholar
15	Schreiber SN, Knutti D, Brogli K, Uhlmann T and Kralli A: The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor α (ERRα). J Biol Chem. 278:9013–9018. 2003. View Article : Google Scholar : PubMed/NCBI
16	Jiang WG, Douglas-Jones A and Mansel RE: Expression of peroxisome-proliferator activated receptor-γ (PPAR-γ) and the PPARγ co-activator, PGC-1, in human breast cancer correlates with clinical outcomes. Int J Cancer. 106:752–757. 2003. View Article : Google Scholar : PubMed/NCBI
17	Watkins G, Douglas-Jones A, Mansel RE and Jiang WG: The localisation and reduction of nuclear staining of PPARγ and PGC-1 in human breast cancer. Oncol Rep. 12:483–488. 2004.PubMed/NCBI
18	Feilchenfeldt J, Bründler MA, Soravia C, Tötsch M and Meier CA: Peroxisome proliferator-activated receptors (PPARs) and associated transcription factors in colon cancer: reduced expression of PPARγ-coactivator 1 (PGC-1). Cancer Lett. 203:25–33. 2004. View Article : Google Scholar
19	Zhang Y, Ba Y, Liu C, Sun G, Ding L, Gao S, Hao J, Yu Z, Zhang J, Zen K, Tong Z, Xiang Y and Zhang CY: PGC-1α induces apoptosis in human epithelial ovarian cancer cells through a PPARγ-dependent pathway. Cell Res. 17:363–373. 2007. View Article : Google Scholar : PubMed/NCBI
20	Cowell RM, Talati P, Blake KR, Meador-Woodruff JH and Russell JW: Identification of novel targets for PGC-1α and histone deacetylase inhibitors in neuroblastoma cells. Biochem Biophys Res Commun. 379:578–582. 2009. View Article : Google Scholar : PubMed/NCBI
21	Shiota M, Yokomizo A, Tada Y, Inokuchi J, Tatsugami K, Kuroiwa K, Uchiumi T, Fujimoto N, Seki N and Naito S: Peroxisome proliferator-activated receptor γ coactivator-1α interacts with the androgen receptor (AR) and promotes prostate cancer cell growth by activating the AR. Mol Endocrinol. 24:114–127. 2010. View Article : Google Scholar
22	Kang W, Nielsen O, Fenger C, Leslie G, Holmskov U and Reid KB: Induction of DMBT1 expression by reduced ERK activity during a gastric mucosa differentiation-like process and its association with human gastric cancer. Carcinogenesis. 26:1129–1137. 2005. View Article : Google Scholar : PubMed/NCBI
23	Kim YJ, Kwak CI, Gu YY, Hwang IT and Chun JY: Annealing control primer system for identification of differentially expressed genes on agarose gels. Biotechniques. 36:424–430. 2004.PubMed/NCBI
24	Shin SW, Seo CY, Han H, Han JY, Jeong JS, Kwak JY and Park JI: 15d-PGJ₂ induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity. Clin Cancer Res. 15:5414–5425. 2009. View Article : Google Scholar : PubMed/NCBI
25	Radkov SA, Kellam P and Boshoff C: The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene H-ras transforms primary rat cells. Nat Med. 6:1121–1127. 2000. View Article : Google Scholar : PubMed/NCBI
26	Valle I, Alvarez-Barrientos A, Arza E, Lamas S and Monsalve M: PGC-1α regulates the mitochondrial antioxidant defense system in vascular endothelial cells. Cardiovasc Res. 66:562–573. 2005. View Article : Google Scholar : PubMed/NCBI
27	Sandberg MB, Bloksgaard M, Duran-Sandoval D, Duval C, Staels B and Mendrup S: The gene encoding acyl-CoA-binding protein is subject to metabolic regulation by both sterol regulatory element-binding protein and peroxisome proliferator-activated receptor α in hepatocytes. J Biol Chem. 280:5258–5266. 2005. View Article : Google Scholar
28	Bhalla K, Hwang BJ, Dewi RE, Qu L, Twaddel W, Fang H, Vafai SB, Vazquez F, Puigserver P, Boros L and Girrun GD: PGC-1α promotes tumor growth by inducing gene expression programs supporting lipogenesis. Cancer Res. 71:6888–6898. 2011. View Article : Google Scholar : PubMed/NCBI
29	Diplock AT, Rice-Evans CA and Burdon RH: Is there a significant role for lipid peroxidation in the causation of malignancy and for antioxidants in cancer prevention? Cancer Res. 54:1952–1965. 1994.
30	Lee JM: Inhibition of p53-dependent apoptosis by the KIT tyrosine kinase: regulation of mitochondrial permeability transition and reactive oxygen species generation. Oncogene. 17:1653–1662. 1998. View Article : Google Scholar : PubMed/NCBI
31	Guha M, Bai W, Nadler JL and Natarajan R: Molecular mechanisms of tumor necrosis factor gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways. J Biol Chem. 275:17728–17739. 2000. View Article : Google Scholar : PubMed/NCBI
32	Borboni P, Condorelli L, De Stefanis P, Sesti G and Lauro R: Modulation of insulin secretion by diazepam binding inhibitor and its processing products. Neuropharmacology. 30:1399–1403. 1991. View Article : Google Scholar : PubMed/NCBI
33	Chen ZW, Agerberth B, Gell K, Andersson M, Mutt V, Ostenson CG, Efendić S, Barros-Söderling J, Persson B and Jörnvall H: Isolation and characterization of porcine diazepam-binding inhibitor, a polypeptide not only of cerebral occurrence but also common in intestinal tissues and with effects on regulation of insulin release. Eur J Biochem. 174:239–245. 1998. View Article : Google Scholar
34	Besman MJ, Yanagibashi K, Lee TD, Kawamura M, Hall PF and Shively JE: Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor. Proc Natl Acad Sci USA. 86:4897–4901. 1989. View Article : Google Scholar : PubMed/NCBI
35	Boujrad N, Hudson JR Jr and Papadopoulos V: Inhibition of hormone-stimulated steroidogenesis in cultured Leydig tumor cells by a cholesterol-linked phosphorothioate oligodeoxynucleotide antisense to diazepam-binding inhibitor. Proc Natl Acad Sci USA. 90:5728–5731. 1993. View Article : Google Scholar : PubMed/NCBI
36	Papadopoulos V and Brown AS: Role of the peripheral-type benzodiazepine receptor and the polypeptide diazepam binding inhibitor in steroidogenesis. J Steroid Biochem Mol Biol. 53:103–110. 1995. View Article : Google Scholar : PubMed/NCBI
37	Garnier M, Boujrad N, Oke BO, Brown AS, Riond J, Ferrara P, Shoyab M, Suarez-Quian CA and Papadopoulos V: Diazepam binding inhibitor is a paracrine/autocrine regulator of Leydig cell proliferation and steroidogenesis: action via peripheral-type benzodiazepine receptor and independent mechanisms. Endocrinology. 132:444–458. 1993.PubMed/NCBI
38	Mukhin AG, Papadopoulos V, Costa E and Krueger KE: Mitochondrial benzodiazepine receptors regulate steroid biosynthesis. Proc Natl Acad Sci USA. 86:9813–9816. 1989. View Article : Google Scholar : PubMed/NCBI
39	Papadopoulos V, Nowzari FB and Krueger KE: Hormone-stimulated steroidogenesis is coupled to mitochondrial benzodiazepine receptors. Tropic hormone action on steroid biosynthesis is inhibited by flunitrazepam. J Biol Chem. 266:3682–3687. 1991.PubMed/NCBI
40	Alho H, Varga V and Krueger KE: Expression of mitochondrial benzodiazepine receptor and its putative endogenous ligand diazepam binding inhibitor in cultured primary astrocytes and C-6 cells: relation to cell growth. Cell Growth Differ. 5:1005–1014. 1994.PubMed/NCBI
41	Venturini I, Zeneroli ML, Corsi L, Baraldi C, Ferrarese C, Pecora N, Frigo M, Alho H, Farina F and Baraldi M: Diazepam binding inhibitor and total cholesterol plasma levels in cirrhosis and hepatocellular carcinoma. Regul Pept. 74:31–34. 1998. View Article : Google Scholar : PubMed/NCBI
42	Hansen JS, Faergeman NJ, Kragelund BB and Knudsen J: Acyl-CoA-binding protein (ACBP) localizes to the endoplasmic reticulum and Golgi in a ligand-dependent manner in mammalian cells. Biochem J. 410:463–472. 2008. View Article : Google Scholar
43	Petrescu AD, Payne HR, Boedecker A, Chao H, Hertz R, Bar-Tana J, Schroeder F and Kier AB: Physical and functional interaction of Acyl-CoA-binding protein with hepatocyte nuclear factor-4α. J Biol Chem. 278:1813–1824. 2003. View Article : Google Scholar
44	Wang L, Wei D, Huang S, Peng Z, Le X, Wu TT, Yao J, Ajani J and Xie K: Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin Cancer Res. 9:6371–6380. 2003.PubMed/NCBI
45	Safe S and Abdelrahim M: Sp transcription factor family and its role in cancer. Eur J Cancer. 41:2438–2448. 2005. View Article : Google Scholar : PubMed/NCBI
46	Yao JC, Wang L, Wei D, Gong W, Hassan M, Wu TT, Mansfield P, Ajani J and Xie K: Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer. Clin Cancer Res. 10:4109–4117. 2003. View Article : Google Scholar
47	Yuan P, Wang L, Wei D, Zhang J, Jia Z, Li Q, Le X, Wang H, Yao J and Xie K: Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin A correlates directly with potent antiangiogenic effects on human pancreatic cancer. Cancer. 110:2682–2690. 2007. View Article : Google Scholar : PubMed/NCBI
48	Jiang Y, Wang L, Gong W, Wei D, Le X, Yao J, Ajani J, Abbruzzese JL, Huang S and Xie K: A high expression level of insulin-like growth factor 1 receptor is associated with increased expression of transcription factor Sp1 and regional lymph node metastasis of human gastric cancer. Clin Exp Metastasis. 21:755–764. 2004. View Article : Google Scholar
49	Lou Z, O’Reilly S, Liang H, Maher VM, Sleight SD and McCormick JJ: Down-regulation of overexpressed sp1 protein in human fibrosarcoma cell lines inhibits tumor formation. Cancer Res. 65:1007–1017. 2005.PubMed/NCBI
50	Nenoi M, Ichimura S, Mita K, Yukawa O and Cartwright IL: Regulation of the catalase gene promoter by Sp1, CCAAT-recognizing factors, and a WT1/Egr-related factor in hydrogen peroxide-resistant HP 100 cells. Cancer Res. 61:5885–5894. 2001.PubMed/NCBI
51	Dhar SK, Xu Y, Chen Y and St Clair DK: Specificity protein 1-dependent p53-mediated suppression of human manganese superoxide dismutase gene expression. J Biol Chem. 281:21698–21709. 2006. View Article : Google Scholar : PubMed/NCBI